Patient-derived organoids in translational oncology and drug screening
Cancer Letters · 2023
DOI: 10.1016/j.canlet.2023.216180 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Letters, 2023. Verfasst von Ruixin Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, and Shanghai Key Laboratory for Gastric Neoplasms, Shangha…. Hauptthemen laut MEDLINE: Endothelial Cells, Neoplasms. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Patient-derived organoids (PDO) are a new biomedical research model that can reconstruct phenotypic and genetic characteristics of the original tissue and are useful for research on pathogenesis and drug screening. To introduce the progression in this field, we review the key factors of constructing organoids derived from epithelial tissues and cancers, covering culture medium and matrix, morphological characteristics, genetic profiles, high-throughput drug screening, and application potential. We also discuss the co-culture system of cancer organoids with tumor microenvironment (TME) associated cells. The co-culture system is widely used in evaluating crosstalk of cancer cells with TME components, such as fibroblasts, endothelial cells, immune cells, and microorganisms. The article provides a prospective for standardized cultivation mode, automatic morphological evaluation, and drug sensitivity screening using high-throughput methods.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, and Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
- Department of General Surgery of Ruijin Hospital, Shanghai Institute of Digestive Surgery, and Shanghai Key Laboratory for Gastric Neoplasms, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. El…
Zitieren
APA
Yang, R., & Yu, Y. (2023). Patient-derived organoids in translational oncology and drug screening. Cancer Letters. https://doi.org/10.1016/j.canlet.2023.216180
Vancouver
Yang R, Yu Y. Patient-derived organoids in translational oncology and drug screening. Cancer Letters. 2023. doi:10.1016/j.canlet.2023.216180
BibTeX
@article{Yang2023,
author = {Yang, Ruixin and Yu, Yingyan},
title = {Patient-derived organoids in translational oncology and drug screening},
journal = {Cancer Letters},
year = {2023},
doi = {10.1016/j.canlet.2023.216180}
}
EUVIMED